Check order status

Become part of a community of book lovers from all over the world and get access to a whole bunch of benefits. Create an account for free

Austrian Post 5.49 € DPD courier 3.99 € DPD point 2.99 €

Contact

How to shop

Help

My account

▸ Empty :-(

Back in Control

Name: Back in Control
Brand: Rowman & Littlefield
SKU: 04945691
Price: 20.89 EUR
Availability: InStock
Author: David Borenstei
ISBN: 9780871319456

A Conventional and Complementary Prescription for Eliminating Back Pain

David Borenstei

Language

English

Book Hardback

Libristo code: 04945691

Publishers Rowman & Littlefield, June 2001

Based on the fact that back pain can be the result of over sixty illnesses, there is no single thera... Full description

Libristo code: 04945691

51 b

20.89 € VAT included

50 % chance We search the world When will I receive my book?

Delivery to Austria

30-day return policy

Customers also purchased

resistencia de los trabajadores en la dictadura de 1976 Claudio Pérez

Paperback

18.69 €

Aspecto En La Perifrasis Verbal En El Espanol de Mexico José G. Coronado Hernández

Paperback

27.19 €

YOUCAT Firmkurs Begleitbuch Nils Baer

Paperback

18.95 €

Propriété, possession et opposabilité Danos

Paperback

67.69 €

Anbindung von Lieferanten an ein Krankenhausinformationssystem am Beispiel ORBIS Thomas Drebing

Paperback

68.00 €

Based on the fact that back pain can be the result of over sixty illnesses, there is no single therapy that can possibly cure all back pain. This is the first book designed to give people the information they need to devise a combination treatment plan. Dr Borenstein educates readers as to what is available today from both conventional medicine and complementary treatments to alleviate back pain, including: Which medical tests are used to determine the causes of back pain; What therapies work together to stop back pain forever; All the latest treatment alternatives from chiropractic, massage, acupuncture, exercise, nutrition to surgery, and medication; Information on the new Cox II inhibitors.